Here, we describe the engineering of VLPs comprising Pfs25 fused to AlMV CP (Pfs25-CP VLP), production of these VLPs in N. benthamiana using the ‘launch’ vector-based transient expression technology, establishment of purification processes, and evaluation of the purified VLPs in mice for TB activity. The gene discussed is CP; the disease is tuberculosis.